Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • patent

    Tag: patent

    You Searched For "patent"
    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

    Medical Dialogues Bureau11 April 2020 1:56 PM IST
    USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Farhat Nasim31 Oct 2019 3:27 PM IST
    In 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
    Fight for Vildagliptin: Natco goes to court against Novartis

    Fight for Vildagliptin: Natco goes to court against Novartis

    Farhat Nasim7 Sept 2019 4:32 PM IST
    Mumbai: Throwing an indirect challenge at patent holder Novartis, drugmaker Natco Pharma has submitted a fresh application in a Hyderabad court...
    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib

    Farhat Nasim1 Sept 2019 2:33 PM IST
    New Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Farhat Nasim30 July 2019 2:08 PM IST
    New Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Meghna A Singhania22 April 2019 2:07 PM IST
    AHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
    Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

    Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

    Farhat Nasim14 April 2019 10:00 AM IST
    "This court approval brings closure to the sale process for Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio,...
    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Suven Life Sciences secures Product Patent in Brazil, Eurasia

    Garima29 March 2019 9:40 AM IST
    The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
    US court upholds dismissal of 200 million dollars Merck verdict against Gilead

    US court upholds dismissal of 200 million dollars Merck verdict against Gilead

    Ruby Khatun Khatun27 April 2018 9:30 AM IST
    A U.S. appeals court affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was not entitled to collect a...
    Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict

    Gilead wins reversal of 2.54 billion dollars hepatitis C drug patent verdict

    Ruby Khatun Khatun19 Feb 2018 9:45 AM IST
    A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs...
    Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

    Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

    Medical Dialogues Bureau28 Jan 2018 9:30 AM IST
    Gene testing company Illumina won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG,...
    France fines Johnson and Johnson 29.6 million dollars over painkiller patch

    France fines Johnson and Johnson 29.6 million dollars over painkiller patch

    Ruby Khatun Khatun21 Dec 2017 10:15 AM IST
    PARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok